Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations

Paolo A. Ascierto, Mariaelena Capone, Antonio M. Grimaldi, Domenico Mallardo, Ester Simeone, Gabriele Madonna, Heinrich Roder, Krista Meyer, Senait Asmellash, Carlos Oliveira, Joanna Roder, Julia Grigorieva

Open source

DOI
10.1186/s40425-019-0569-1
Published
2019-03-29
Container
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40425-019-0569-1,
  title = {Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations},
  author = {Paolo A. Ascierto and Mariaelena Capone and Antonio M. Grimaldi and Domenico Mallardo and Ester Simeone and Gabriele Madonna and Heinrich Roder and Krista Meyer and Senait Asmellash and Carlos Oliveira and Joanna Roder and Julia Grigorieva},
  year = {2019},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1186/s40425-019-0569-1},
  url = {https://doi.org/10.1186/s40425-019-0569-1}
}

RIS

TY  - JOUR
TI  - Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
AU  - Paolo A. Ascierto
AU  - Mariaelena Capone
AU  - Antonio M. Grimaldi
AU  - Domenico Mallardo
AU  - Ester Simeone
AU  - Gabriele Madonna
AU  - Heinrich Roder
AU  - Krista Meyer
AU  - Senait Asmellash
AU  - Carlos Oliveira
AU  - Joanna Roder
AU  - Julia Grigorieva
PY  - 2019
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1186/s40425-019-0569-1
UR  - https://doi.org/10.1186/s40425-019-0569-1
ER  - 

APA

Ascierto, P. A., Capone, M., Grimaldi, A. M., Mallardo, D., Simeone, E., Madonna, G., Roder, H., Meyer, K., Asmellash, S., Oliveira, C., Roder, J., & Grigorieva, J. (2019). Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1186/s40425-019-0569-1

Source records